Familial cerebral amyloid angiopathies and dementia

Blas Frangione, Ruben Vidal, Agueda Rostagno, Jorge Ghiso

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Amyloidosis is a disorder of protein conformation leading to aggregation. The term defines a diverse group of proteins normally present in body fluids as soluble precursors that can be deposited as insoluble amyloid fibrils in different tissues producing organ dysfunction and cell death. These fibrils are composed of self-assembled, low molecular weight mass peptides adopting β-pleated sheet structure, the conformation responsible for their physicochemical properties and tinctoreal characteristics. So far, 20 different proteins have been identified as subunits of amyloid fibrils. Collectively, they are products of normal genes; however, several amyloid precursors contain abnormal amino acid substitutions that can impose an unusual potential for self-aggregation. The molecular mass of the amyloid peptides is within the 4 to 30-kDa range, with heterogeneity at the amino- and carboxyl-terminal portions found in most amyloid proteins. Increased levels of amyloid precursors, either in the circulation or locally in sites of deposition, are usually the result of overexpression or defective clearance, or both. Of the 20 amyloid proteins identified, few of them are known to cause amyloid deposition in the central nervous system, which in turn results in cognitive deficits, dementia, stroke, cerebellar and extrapyramidal signs, or a combination of them.

Original languageEnglish (US)
Pages (from-to)S25-S30
JournalAlzheimer disease and associated disorders
Volume14
Issue numberSUPPL. 1
DOIs
StatePublished - Jul 6 2000

Fingerprint

Familial Cerebral Amyloid Angiopathy
Amyloid
Dementia
Amyloidogenic Proteins
Peptides
Protein Conformation
Body Fluids
Amyloidosis
Amino Acid Substitution
Proteins
Cell Death
Central Nervous System
Molecular Weight
Stroke

Keywords

  • Cerebral hemorrhage
  • Congophilic angiopathy
  • Familial British dementia
  • HCHWA-D
  • HCHWA-I

ASJC Scopus subject areas

  • Clinical Psychology
  • Gerontology
  • Geriatrics and Gerontology
  • Psychiatry and Mental health

Cite this

Familial cerebral amyloid angiopathies and dementia. / Frangione, Blas; Vidal, Ruben; Rostagno, Agueda; Ghiso, Jorge.

In: Alzheimer disease and associated disorders, Vol. 14, No. SUPPL. 1, 06.07.2000, p. S25-S30.

Research output: Contribution to journalArticle

Frangione, Blas ; Vidal, Ruben ; Rostagno, Agueda ; Ghiso, Jorge. / Familial cerebral amyloid angiopathies and dementia. In: Alzheimer disease and associated disorders. 2000 ; Vol. 14, No. SUPPL. 1. pp. S25-S30.
@article{42f14aa5a2514b2ca760f2f482042f67,
title = "Familial cerebral amyloid angiopathies and dementia",
abstract = "Amyloidosis is a disorder of protein conformation leading to aggregation. The term defines a diverse group of proteins normally present in body fluids as soluble precursors that can be deposited as insoluble amyloid fibrils in different tissues producing organ dysfunction and cell death. These fibrils are composed of self-assembled, low molecular weight mass peptides adopting β-pleated sheet structure, the conformation responsible for their physicochemical properties and tinctoreal characteristics. So far, 20 different proteins have been identified as subunits of amyloid fibrils. Collectively, they are products of normal genes; however, several amyloid precursors contain abnormal amino acid substitutions that can impose an unusual potential for self-aggregation. The molecular mass of the amyloid peptides is within the 4 to 30-kDa range, with heterogeneity at the amino- and carboxyl-terminal portions found in most amyloid proteins. Increased levels of amyloid precursors, either in the circulation or locally in sites of deposition, are usually the result of overexpression or defective clearance, or both. Of the 20 amyloid proteins identified, few of them are known to cause amyloid deposition in the central nervous system, which in turn results in cognitive deficits, dementia, stroke, cerebellar and extrapyramidal signs, or a combination of them.",
keywords = "Cerebral hemorrhage, Congophilic angiopathy, Familial British dementia, HCHWA-D, HCHWA-I",
author = "Blas Frangione and Ruben Vidal and Agueda Rostagno and Jorge Ghiso",
year = "2000",
month = "7",
day = "6",
doi = "10.1097/00002093-200000001-00005",
language = "English (US)",
volume = "14",
pages = "S25--S30",
journal = "Alzheimer Disease and Associated Disorders",
issn = "0893-0341",
publisher = "Lippincott Williams and Wilkins",
number = "SUPPL. 1",

}

TY - JOUR

T1 - Familial cerebral amyloid angiopathies and dementia

AU - Frangione, Blas

AU - Vidal, Ruben

AU - Rostagno, Agueda

AU - Ghiso, Jorge

PY - 2000/7/6

Y1 - 2000/7/6

N2 - Amyloidosis is a disorder of protein conformation leading to aggregation. The term defines a diverse group of proteins normally present in body fluids as soluble precursors that can be deposited as insoluble amyloid fibrils in different tissues producing organ dysfunction and cell death. These fibrils are composed of self-assembled, low molecular weight mass peptides adopting β-pleated sheet structure, the conformation responsible for their physicochemical properties and tinctoreal characteristics. So far, 20 different proteins have been identified as subunits of amyloid fibrils. Collectively, they are products of normal genes; however, several amyloid precursors contain abnormal amino acid substitutions that can impose an unusual potential for self-aggregation. The molecular mass of the amyloid peptides is within the 4 to 30-kDa range, with heterogeneity at the amino- and carboxyl-terminal portions found in most amyloid proteins. Increased levels of amyloid precursors, either in the circulation or locally in sites of deposition, are usually the result of overexpression or defective clearance, or both. Of the 20 amyloid proteins identified, few of them are known to cause amyloid deposition in the central nervous system, which in turn results in cognitive deficits, dementia, stroke, cerebellar and extrapyramidal signs, or a combination of them.

AB - Amyloidosis is a disorder of protein conformation leading to aggregation. The term defines a diverse group of proteins normally present in body fluids as soluble precursors that can be deposited as insoluble amyloid fibrils in different tissues producing organ dysfunction and cell death. These fibrils are composed of self-assembled, low molecular weight mass peptides adopting β-pleated sheet structure, the conformation responsible for their physicochemical properties and tinctoreal characteristics. So far, 20 different proteins have been identified as subunits of amyloid fibrils. Collectively, they are products of normal genes; however, several amyloid precursors contain abnormal amino acid substitutions that can impose an unusual potential for self-aggregation. The molecular mass of the amyloid peptides is within the 4 to 30-kDa range, with heterogeneity at the amino- and carboxyl-terminal portions found in most amyloid proteins. Increased levels of amyloid precursors, either in the circulation or locally in sites of deposition, are usually the result of overexpression or defective clearance, or both. Of the 20 amyloid proteins identified, few of them are known to cause amyloid deposition in the central nervous system, which in turn results in cognitive deficits, dementia, stroke, cerebellar and extrapyramidal signs, or a combination of them.

KW - Cerebral hemorrhage

KW - Congophilic angiopathy

KW - Familial British dementia

KW - HCHWA-D

KW - HCHWA-I

UR - http://www.scopus.com/inward/record.url?scp=0034130213&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034130213&partnerID=8YFLogxK

U2 - 10.1097/00002093-200000001-00005

DO - 10.1097/00002093-200000001-00005

M3 - Article

C2 - 10850727

AN - SCOPUS:0034130213

VL - 14

SP - S25-S30

JO - Alzheimer Disease and Associated Disorders

JF - Alzheimer Disease and Associated Disorders

SN - 0893-0341

IS - SUPPL. 1

ER -